Skip to main content
Figure 2 | Cardiovascular Diabetology

Figure 2

From: Liraglutide attenuates high glucose-induced abnormal cell migration, proliferation, and apoptosis of vascular smooth muscle cells by activating the GLP-1 receptor, and inhibiting ERK1/2 and PI3K/Akt signaling pathways

Figure 2

Liraglutide (LIRA) inhibited high glucose (HG)-induced proliferation in cultured vascular smooth muscle cells. Cell proliferation was determined using Cell Counting Kit-8. All results are presented as mean ± standard deviation from three independent experiments; * p < 0.01 vs. control; # p < 0.01 vs. HG. MG = mannitol, osmotic control; OD = optical density.

Back to article page

Cardiovascular Diabetology

ISSN: 1475-2840